Pancreatic Cancer Research

ResearcherNorthwestern UniversityNo recent work listed

Celso L. Diaz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5666-3722; OpenAlex author ID A5055638556. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 2 papers

Papers 2

  1. CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1097/coc.0000000000000620↗
  2. Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma. First author DOI 10.1097/mpa.0000000000001354↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew H. Ko · 2 shared papers, 2019 · strength 0.24
  2. Jimmy J. Hwang · 2 shared papers, 2019 · strength 0.24
  3. Margaret A. Tempero · 2 shared papers, 2019 · strength 0.24
  4. Pelin Cinar · 1 shared paper, 2019 · strength 0.12
  5. Claire Johns · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.